LiliumX unveils rebrand as Valink Therapeutics and appointment of new board and execs after securing $7.8m investment
LiliumX, an innovative BioTech start-up focused on the development of next generation antibody-based therapeutics, has unveiled its new brand name and welcomed three top industry leaders to the business, after securing $7.8 million (£6.3 million) in investment. LiliumX was founded in 2021 by co-founders Arne Scheu and Irsyad Khairil, following their own research into “LEGO” […]